Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Alzheimer's Disease

  Free Subscription

Articles published in JAMA

Retrieve available abstracts of 40 articles:
HTML format

Single Articles

    September 2021
  1. ANDERSON TS, Ayanian JZ, Souza J, Landon BE, et al
    Representativeness of Participants Eligible to Be Enrolled in Clinical Trials of Aducanumab for Alzheimer Disease Compared With Medicare Beneficiaries With Alzheimer Disease and Mild Cognitive Impairment.
    JAMA. 2021 Sep 9. pii: 2784225. doi: 10.1001/jama.2021.15286.

    August 2021
  2. RUBIN R
    CMS Considers Controversial Alzheimer Drug Coverage.
    JAMA. 2021;326:690.

    July 2021
  3. RUBIN R
    Recently Approved Alzheimer Drug Raises Questions That Might Never Be Answered.
    JAMA. 2021 Jul 21. pii: 2782427. doi: 10.1001/jama.2021.11558.

  4. SCHULMAN KA, Greicius MD, Richman B
    Will CMS Find Aducanumab Reasonable and Necessary for Alzheimer Disease After FDA Approval?
    JAMA. 2021 Jul 19. pii: 2782333. doi: 10.1001/jama.2021.11768.

    June 2021
  5. CHEN MH, Yang FC, Liang CS
    APOE Allele Testing and Alzheimer Disease.
    JAMA. 2021;325:2210-2211.

  6. CHOUDHURY P, Ramanan VK, Boeve BF
    APOE Allele Testing and Alzheimer Disease-Reply.
    JAMA. 2021;325:2211.

    April 2021
  7. RUBIN R
    Neurologist Faces His Alzheimer Diagnosis Determined to Lessen Stigma Surrounding the Disease.
    JAMA. 2021 Apr 28. pii: 2779452. doi: 10.1001/jama.2021.5333.

    March 2021
  8. ALEXANDER GC, Emerson S, Kesselheim AS
    Evaluation of Aducanumab for Alzheimer Disease: Scientific Evidence and Regulatory Review Involving Efficacy, Safety, and Futility.
    JAMA. 2021 Mar 30. pii: 2778191. doi: 10.1001/jama.2021.3854.

    January 2021
  9. CHOUDHURY P, Ramanan VK, Boeve BF
    APOE varepsilon4 Allele Testing and Risk of Alzheimer Disease.
    JAMA. 2021 Jan 14. pii: 2775399. doi: 10.1001/jama.2020.15085.

    November 2020
  10. MADDOX M
    Alzheimer Aubade.
    JAMA. 2020;324:2108.

    October 2020
  11. TSOU AY, Bulova P, Capone G, Chicoine B, et al
    Medical Care of Adults With Down Syndrome: A Clinical Guideline.
    JAMA. 2020;324:1543-1556.
    PubMed     Abstract available

    July 2020
  12. PALMQVIST S, Janelidze S, Quiroz YT, Zetterberg H, et al
    Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.
    JAMA. 2020 Jul 28. pii: 2768841. doi: 10.1001/jama.2020.12134.
    PubMed     Abstract available

    June 2020
    Can Infections Cause Alzheimer Disease?
    JAMA. 2020 Jun 8. pii: 2767210. doi: 10.1001/jama.2020.4085.

    April 2020
  14. ABBASI J
    Alzheimer Blood Test Using Tau Biomarker Is in Development.
    JAMA. 2020;323:1336.

    February 2020
  15. PATNODE CD, Perdue LA, Rossom RC, Rushkin MC, et al
    Screening for Cognitive Impairment in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2020;323:764-785.
    PubMed     Abstract available

  16. ABBASI J
    Ultrasound Brain Stimulation Piloted in Alzheimer Study.
    JAMA. 2020;323:499.

  17. BORELLI CM, Grennan D, Muth CC
    Causes of Memory Loss in Elderly Persons.
    JAMA. 2020;323:486.

    January 2020
  18. KUEHN BM
    In Alzheimer Research, Glucose Metabolism Moves to Center Stage.
    JAMA. 2020 Jan 8. pii: 2758712. doi: 10.1001/jama.2019.20939.

    October 2019
  19. ARVANITAKIS Z, Shah RC, Bennett DA
    Diagnosis and Management of Dementia: Review.
    JAMA. 2019;322:1589-1599.
    PubMed     Abstract available

    July 2019
    For Alzheimer Pathology, Light and Sound Stimulation May Hold Promise.
    JAMA. 2019;322:17-18.

    June 2019
  21. WOLK D, Salloway S, Dickerson B
    Putting the New Alzheimer Disease Amyloid, Tau, Neurodegeneration (AT[N]) Diagnostic System to the Test.
    JAMA. 2019;321:2289-2291.

    April 2019
    Studies Further Support Transmissibility of Alzheimer Disease-Associated Proteins.
    JAMA. 2019;321:1243-1244.

  23. RABINOVICI GD, Gatsonis C, Apgar C, Chaudhary K, et al
    Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia.
    JAMA. 2019;321:1286-1294.
    PubMed     Abstract available

    December 2018
  24. GLAZNER G, Kaplan DB
    The Alzheimer's Poetry Project.
    JAMA. 2018;320:2294-2295.

    November 2018
  25. KUEHN B
    Alzheimer Burden.
    JAMA. 2018;320:1851.

    September 2018
  26. OSSENKOPPELE R, Rabinovici GD, Smith R, Cho H, et al
    Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.
    JAMA. 2018;320:1151-1162.
    PubMed     Abstract available

  27. ABBASI J
    Promising Results in 18-Month Analysis of Alzheimer Drug Candidate.
    JAMA. 2018;320:965.

    June 2018
    Abeta-Clearing Drug Fails to Slow Alzheimer Disease.
    JAMA. 2018;319:2470.

    March 2018
  29. ABBASI J
    Plasma Biomarkers Predict Brain Amyloid-beta Burden.
    JAMA. 2018;319:972.

    January 2018
  30. ATRI A, Frolich L, Ballard C, Tariot PN, et al
    Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials.
    JAMA. 2018;319:130-142.
    PubMed     Abstract available

    Lack of Benefit With Idalopirdine for Alzheimer Disease: Another Therapeutic Failure in a Complex Disease Process.
    JAMA. 2018;319:123-125.

    October 2017
  32. ABBASI J
    A Retinal Scan for Alzheimer Disease.
    JAMA. 2017;318:1314.

  33. DONOHUE MC, Aisen PS
    Elevated Brain Amyloid in Cognitively Normal Individuals-Reply.
    JAMA. 2017;318:1393-1394.

  34. GAO R, Chen C, Zhu T
    Elevated Brain Amyloid in Cognitively Normal Individuals.
    JAMA. 2017;318:1392-1393.

    June 2017
  35. VISSER PJ, Tijms B
    Brain Amyloid Pathology and Cognitive Function: Alzheimer Disease Without Dementia?
    JAMA. 2017;317:2285-2287.

  36. DONOHUE MC, Sperling RA, Petersen R, Sun CK, et al
    Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons.
    JAMA. 2017;317:2305-2316.
    PubMed     Abstract available

    May 2017
  37. SABAYAN B, Sorond F
    Reducing Risk of Dementia in Older Age.
    JAMA. 2017;317:2028.

    April 2017
  38. GOTTESMAN RF, Schneider AL, Zhou Y, Coresh J, et al
    Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition.
    JAMA. 2017;317:1443-1450.
    PubMed     Abstract available

    February 2017
  39. LYON J
    Alzheimer Outlook Far From Bleak.
    JAMA. 2017 Feb 15. doi: 10.1001/jama.2017.0276.

    December 2016
  40. LYON J
    Study Suggests Alzheimer and Parkinson Disease Are Not Transmitted Through Blood Transfusion.
    JAMA. 2016 Dec 21. doi: 10.1001/jama.2016.16260.

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.